BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11170687)

  • 1. Three new hyperforin analogues from Hypericum perforatum.
    Shan MD; Hu LH; Chen ZL
    J Nat Prod; 2001 Jan; 64(1):127-30. PubMed ID: 11170687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperforin analogues from St. John's wort (Hypericum perforatum).
    Verotta L; Appendino G; Jakupovic J; Bombardelli E
    J Nat Prod; 2000 Mar; 63(3):412-5. PubMed ID: 10757735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemical constituents of Hypericum perforatum].
    Shi MJ; Hu JW; Wang JJ; Zhen B; Wang X; Ji TF
    Zhongguo Zhong Yao Za Zhi; 2018 Jul; 43(13):2726-2731. PubMed ID: 30111023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further degradation product of hyperforin from Hypericum perforatum (St John's Wort).
    Vajs V; Vugdelija S; Trifunović S; Karadzić I; Juranić N; Macura S; Milosavljević S
    Fitoterapia; 2003 Jul; 74(5):439-44. PubMed ID: 12837358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of eluent pH on the HPLC-UV analysis of hyperforin from St. John's Wort (Hypericum perforatum L.).
    Fourneron JD; Naït-Si Y
    Phytochem Anal; 2006; 17(2):71-7. PubMed ID: 16634282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential accumulation of hyperforin and secohyperforin in Hypericum perforatum tissue cultures.
    Charchoglyan A; Abrahamyan A; Fujii I; Boubakir Z; Gulder TA; Kutchan TM; Vardapetyan H; Bringmann G; Ebizuka Y; Beerhues L
    Phytochemistry; 2007 Nov; 68(21):2670-7. PubMed ID: 17643455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three new phloroglucinol derivatives from Hypericum scabrum.
    Ma J; Ji TF; Yang JB; Wang AG; Su YL
    J Asian Nat Prod Res; 2012; 14(5):508-14. PubMed ID: 22530678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation products of hyperforin from Hypericum perforatum.
    Trifunović S; Vajs V; Macura S; Juranić N; Djarmati Z; Jankov R; Milosavljević S
    Phytochemistry; 1998 Nov; 49(5):1305-10. PubMed ID: 9842729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperforin.
    Beerhues L
    Phytochemistry; 2006 Oct; 67(20):2201-7. PubMed ID: 16973193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of hyperforin a constituent of St. John's wort in plasma by high-performance liquid chromatography.
    Chi JD; Franklin M
    J Chromatogr B Biomed Sci Appl; 1999 Dec; 735(2):285-8. PubMed ID: 10670742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperforin, possibly the major non-nitrogenous secondary metabolite of Hypericum perforatum L.
    Erdelmeier CA
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():2-6. PubMed ID: 9684941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperforin in extracts of St John's wort (Hypericum perforatum) for depression.
    Vormfelde SV; Poser W
    Arch Intern Med; 2000 Sep; 160(16):2548-9. PubMed ID: 10979074
    [No Abstract]   [Full Text] [Related]  

  • 14. The production of hypericins and hyperforin by in vitro cultures of St. John's wort (Hypericum perforatum).
    Kirakosyan A; Sirvent TM; Gibson DM; Kaufman PB
    Biotechnol Appl Biochem; 2004 Feb; 39(Pt 1):71-81. PubMed ID: 14521510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells.
    Schempp CM; Winghofer B; Lüdtke R; Simon-Haarhaus B; Schöpf E; Simon JC
    Br J Dermatol; 2000 May; 142(5):979-84. PubMed ID: 10809859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of hyperforin analogues for inhibition of 5-lipoxygenase.
    Feisst C; Albert D; Verotta L; Werz O
    Med Chem; 2005 May; 1(3):287-91. PubMed ID: 16787324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
    Muruganandam AV; Bhattacharya SK; Ghosal S
    Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
    J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple and reliable semipreparative high-performance liquid chromatography technique for the isolation of marker-grade hyperforin from Hypericum perforatum L extract.
    Anand R; Puri SC; Verma N; Handa G; Khajuria RK; Gupta VK; Suri OP; Qazi GN
    J Chromatogr Sci; 2003 Sep; 41(8):444-6. PubMed ID: 14558939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural investigations of isomeric oxidised forms of hyperforin by HPLC-NMR and HPLC-MSn.
    Wolfender JL; Verotta L; Belvisi L; Fuzzati N; Hostettmann K
    Phytochem Anal; 2003; 14(5):290-7. PubMed ID: 14516001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.